Back to VANGUARD GROUP INC

RXRX
6 quarters

Position history for VANGUARD GROUP INC's holdings in RECURSION PHARMACEUTICALS IN

VANGUARD GROUP INC holds 47.2M shares of RXRX (RECURSION PHARMACEUTICALS IN), worth $193M as of 2025-Q4. The position was increased (+18.6% shares). RXRX represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$193M

Current Shares

47.2M

Total Value Change

+$33M

Total Shares Change

+22.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
47.2M
+18.6%
$193M0.0%$4.11
36
2025-Q3
Increased
39.8M
+10.3%
$194.1M0.0%$4.91
34
2025-Q2
Increased
36.1M
+11.7%
$182.5M0.0%$5.03
34
2025-Q1
Decreased
32.3M
-5.1%
$170.8M0.0%$5.81
0
2024-Q4
Increased
34M
+40.1%
$229.9M0.0%$6.77
41
2024-Q3
New
24.3M
-
$160M0.0%$6.98
42

Other major holders of RXRX: BAILLIE GIFFORD & CO, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used